Dr Sue Astley
University of Manchester
Sue Astley leads research in breast radiomics at the University of Manchester. Her work includes evaluation of novel imaging technologies (CAD, DBT), developing software to detect abnormalities and discover imaging biomarkers, using eye tracking to learn how new imaging systems are best employed, and working closely with radiologists to achieve clinically useful solutions. As breast density lead for the 55,000 strong Predicting Risk of Cancer At Screening (PROCAS) study she has focused her attention on markers of breast cancer risk, harnessing the power of deep learning to exploit the trial data and improve risk prediction.
Deep learning for breast density assessment and risk prediction
I will review the importance of breast density assessment for cancer risk prediction, identifying women for whom mammography is less effective, and assessing the efficacy of risk reducing interventions. I will then discuss current methods for density assessment, looking at the strengths and limitations of different approaches. Finally, I will describe density assessment using convolutional neural networks, including a review of the issues associated with developing and validating such approaches.
EVEN MORE SEMINARS
Carlos Schorlemmer Telemedicine Clinic
Innovative e-training platforms: key for quality diagnostic imaging reporting
Laura Allington University College London Hospitals NHS Foundation Trust
Operational challenges of planning a new NHS high energy proton service
Dr Sarah Brüningk The Institute of Cancer Research
The role of ultrasound therapy in cancer treatments
Matthew Gardner RRPPS, University Hospitals Birmingham NHS Foundation Trust
Patient dosimetry audit for nuclear medicine and radiotherapy planning CT
Prof Alan Perkins University of Nottingham
Optical-Gamma Camera Imaging in Nuclear Medicine